Avian Influenza, MDR-TB and the 2026 Infectious Disease Watchlist
DocSite AI Team
April 28, 2026
Five years out from the COVID pandemic, the infectious disease world is watching three slower-moving but consequential threats in 2026: H5N1 avian influenza, drug-resistant tuberculosis, and steady antimicrobial resistance.
H5N1 avian influenza in 2026
- Cattle and dairy outbreaks since 2024 have produced sporadic human cases, mostly mild — but the surveillance picture is patchy.
- Pandemic preparedness reactivated — H5N1-specific candidate vaccines exist and antivirals (oseltamivir, baloxavir) remain effective.
- Occupational exposure in dairy and poultry workers is the current human risk; PPE and surveillance are essential.
Drug-resistant TB
- BPaL and BPaLM regimens (bedaquiline-based) have shortened MDR-TB treatment from 18+ months to 6 months in many cases.
- India remains the highest-burden country — early detection and adherence support are the levers.
- Genotypic drug-susceptibility testing is increasingly accessible and shortens time-to-effective-therapy.
Antimicrobial resistance — the slow crisis
- Carbapenem-resistant Enterobacteriaceae (CRE) are now common in many hospital ICUs in South and Southeast Asia.
- Newer agents (cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam) work but stewardship is essential.
- Antibiotic stewardship is everyone's job — including the patient who finishes the course or doesn't ask for antibiotics for viral colds.
What this means for patients and practising clinicians
These are not headline-grabbing pandemics — they are the steady, structural threats. The patient-facing version is simple: don't push for unnecessary antibiotics, complete the courses you do need, get TB symptoms (cough > 3 weeks, weight loss, fever) checked promptly, and follow public-health guidance on H5N1 if you work with poultry or dairy.
*This article was drafted by the DocSite AI Team and reviewed for clinical accuracy. It is general medical information, not personal medical advice. For decisions about your own care, please consult a qualified specialist on DocSite.*
Frequently Asked Questions
Should I worry about bird flu?
Routine general public risk remains low. Occupational exposure (poultry, dairy) requires PPE and surveillance. Stay informed via national health authorities.
Why has TB treatment got shorter?
Newer drug regimens (BPaL/BPaLM) shorten effective MDR-TB therapy substantially while maintaining cure rates. This is one of the biggest TB advances in decades.
How can I help fight antibiotic resistance?
Don't pressure clinicians for antibiotics for viral illnesses, complete prescribed courses, and avoid leftover antibiotic use.
Book a consult with your Specialist Infectious Disease Specialist
Find practising infectious disease specialists on DocSite and book directly — no middlemen, no paid rankings.
Find a Infectious Disease Specialist